Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Patients who have been treated for cervical cancer using a combination of chemotherapy, radiation, and brachytherapy (internal radiation) as part of a clinical trial, and who have MRI or CT scan images available from the time of their diagnosis and brachytherapy treatment
- Patients who are receiving or have received radiation therapy after surgery, or as a primary treatment for their condition, as part of a clinical trial
Who may not be able to join:
- People whose records do not include information about how their disease progressed or any side effects from treatment
- People whose scan images (such as MRI or CT scans) are not available in the hospital's records system
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Supriya Sastri (nee Chopra), MD, Tata Memorial Centre, The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
Phone: 02227405000
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Generation of software for automated target delineation for cervix cancer; Development and validation of Normal Tissue Complication Plots; Identify "high risk patient population" that may benefit from intensification of treatment in future
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.